- Home
- MESA vs KPTI Comparison
MESA vs KPTI Comparison
Compare MESA & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MESA
- KPTI
- Stock Information
- Founded
- MESA 1982
- KPTI 2008
- Country
- MESA United States
- KPTI United States
- Employees
- MESA N/A
- KPTI N/A
- Industry
- MESA Air Freight/Delivery Services
- KPTI Biotechnology: Pharmaceutical Preparations
- Sector
- MESA Consumer Discretionary
- KPTI Health Care
- Exchange
- MESA Nasdaq
- KPTI Nasdaq
- Market Cap
- MESA 29.1M
- KPTI 33.6M
- IPO Year
- MESA 2018
- KPTI 2013
- Fundamental
- Price
- MESA $1.17
- KPTI $6.27
- Analyst Decision
- MESA
- KPTI Strong Buy
- Analyst Count
- MESA 0
- KPTI 5
- Target Price
- MESA N/A
- KPTI $61.00
- AVG Volume (30 Days)
- MESA 3.2M
- KPTI 154.7K
- Earning Date
- MESA 06-17-2025
- KPTI 05-07-2025
- Dividend Yield
- MESA N/A
- KPTI N/A
- EPS Growth
- MESA N/A
- KPTI N/A
- EPS
- MESA N/A
- KPTI N/A
- Revenue
- MESA $475,518,000.00
- KPTI $145,237,000.00
- Revenue This Year
- MESA $15.09
- KPTI $4.87
- Revenue Next Year
- MESA $16.19
- KPTI $16.29
- P/E Ratio
- MESA N/A
- KPTI N/A
- Revenue Growth
- MESA N/A
- KPTI N/A
- 52 Week Low
- MESA $0.68
- KPTI $3.51
- 52 Week High
- MESA $1.89
- KPTI $18.00
- Technical
- Relative Strength Index (RSI)
- MESA 63.25
- KPTI 62.17
- Support Level
- MESA $1.05
- KPTI $3.83
- Resistance Level
- MESA $1.13
- KPTI $4.36
- Average True Range (ATR)
- MESA 0.10
- KPTI 0.45
- MACD
- MESA 0.03
- KPTI 0.39
- Stochastic Oscillator
- MESA 89.09
- KPTI 90.49
About MESA Mesa Air Group Inc.
Mesa Air Group Inc is a regional air carrier providing scheduled passenger service. It provides scheduled passenger service to 86 cities in 36 states, the District of Columbia, Canada, Cuba, and Mexico as well as cargo services out of Cincinnati/Northern Kentucky International Airport. Flights are operated as American Eagle, United Express, or DHL Express flights to the terms of capacity purchase agreements with American and United and a flight services agreement with DHL. The business has a presence in domestic hubs and cities, including Dallas, Houston, Phoenix, and Washington-Dulles and other regions.
About KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.